| Product Code: ETC5359016 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In 2024, Ireland`s buprenorphine import market saw a shift in concentration, with top exporters being Switzerland, Belgium, USA, UK, and China. The market experienced a significant decrease in concentration from 2023 to 2024, indicating a more diverse import landscape. Despite a negative growth rate of -47.44% in 2024, the compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 11.32%, suggesting overall steady growth in the buprenorphine import market in Ireland over the past few years.

By 2027, the Buprenorphine market in Ireland is anticipated to reach a growth rate of 0.00%, as part of an increasingly competitive Europe region, where Germany remains at the forefront, supported by United Kingdom, France, Italy and Russia, driving innovations and market adoption across sectors.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Buprenorphine Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Buprenorphine Market - Industry Life Cycle |
3.4 Ireland Buprenorphine Market - Porter's Five Forces |
3.5 Ireland Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Ireland Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Ireland Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about opioid addiction and the benefits of buprenorphine treatment |
4.2.2 Growing government initiatives to combat opioid abuse and support addiction treatment programs |
4.2.3 Rising healthcare expenditure and accessibility to buprenorphine treatment |
4.3 Market Restraints |
4.3.1 Stringent regulations and monitoring requirements for buprenorphine prescription and dispensing |
4.3.2 Limited availability of healthcare professionals trained in prescribing buprenorphine |
4.3.3 Stigma and misconceptions surrounding opioid addiction and medication-assisted treatment |
5 Ireland Buprenorphine Market Trends |
6 Ireland Buprenorphine Market Segmentations |
6.1 Ireland Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Ireland Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 Ireland Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Ireland Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Ireland Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Ireland Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Ireland Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Ireland Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Ireland Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Ireland Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Ireland Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Ireland Buprenorphine Market Import-Export Trade Statistics |
7.1 Ireland Buprenorphine Market Export to Major Countries |
7.2 Ireland Buprenorphine Market Imports from Major Countries |
8 Ireland Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering buprenorphine treatment |
8.2 Percentage increase in patients opting for buprenorphine therapy |
8.3 Rate of successful treatment outcomes with buprenorphine therapy |
9 Ireland Buprenorphine Market - Opportunity Assessment |
9.1 Ireland Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Ireland Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Ireland Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Buprenorphine Market - Competitive Landscape |
10.1 Ireland Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Ireland Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here